Mike Brennan, CEO of Norman Broadbent, said: “The award is a huge recognition for our team who have shown considerable commitment during the successful transformation of the Norman Broadbent Group...
Fox Marble Holdings plc (LON:FOX) Chief Executive Officer Chris Gilbert caught up with DirectorsTalk for an exclusive interview to discuss the key factors of their final results, progress in 2019..
Palace Capital’s results (4 June) show 37 new leases were completed. Most importantly, these were 14% above ERV (i.e. the level which previous valuers had estimated). This is one of..
W Resources plc (LON:WRES) Chairman Michael Masterman caught up with DirectorsTalk for an exclusive interview to discuss their latest La Parrilla update. Q1: Michael, when we last spoke, you’d had..
Bushveld Minerals Limited (LON: BMN), the AIM listed, integrated primary vanadium producer, with ownership of high grade vanadium assets in South Africa, has today announced, that its 84%-owned energy subsidiary,..
EQTEC plc (LON:EQT) Chief Executive Officer Ian Price caught up with DirectorsTalk for an exclusive interview to discuss the agreement to acquire 19.99% ownership of North Fork Community Power. Q1:..
The Board of Woodford Patient Capital Trust plc (LON:WPCT) notes the recent developments at Woodford Investment Management Ltd. Following the events relating to LF Woodford Equity Income Fund, the Board..
HgCapital Trust plc (LON: HGT) is a FTSE 250 company which provides investors with exposure to a fast-growing network of unquoted investments, primarily in European software and service businesses. The..
CONTINUED GROWTH, RE-AFFIRMING GUIDANCE, $500 MILLION SHARE BUY BACK Ongoing businesses1US$ millions Q3 2019 Q3 2018 Change Revenue 5,274 4,968 +6.2% Trading profit2 359 351 +2.3% Net debt to EBITDA ..
The Board of Accrol Group Holdings plc (LON: ACRL) has today announced the following trading update ahead of its results for the full year ended 30 April 2019, which will..
Avacta Group plc (LON: AVCT), the developer of Affimer® biotherapeutics and research reagents, announced today that it has selected the clinical development candidate for first-time-in-human clinical trials of the Affimer..
Live Company Group plc (LON: LVCG) has today announced that the Group has entered into an agreement with SMG Europe Holdings Limited, an events venue management company, to promote the..
